Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Other financing activities (2023 - 2026)

Cresco Labs filings provide 3 years of Other financing activities readings, the most recent being -$10000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities rose 96.89% to -$10000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $14.7 million, a N/A change, with the full-year FY2025 number at $14.4 million, changed N/A from a year prior.
  • Other financing activities hit -$10000.0 in Q1 2026 for Cresco Labs, down from $28.7 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $28.7 million in Q4 2025 to a low of -$14.2 million in Q3 2025.
  • Median Other financing activities over the past 3 years was $70500.0 (2025), compared with a mean of $3.0 million.
  • The widest YoY moves for Other financing activities: up 96.89% in 2026, down 96.89% in 2026.
  • Cresco Labs' Other financing activities stood at $3.9 million in 2023, then skyrocketed by 637.96% to $28.7 million in 2025, then plummeted by 100.03% to -$10000.0 in 2026.
  • The last three reported values for Other financing activities were -$10000.0 (Q1 2026), $28.7 million (Q4 2025), and -$14.2 million (Q3 2025) per Business Quant data.